🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesSemaglutide cardiovascular benefit independent of weight loss Page 3

Semaglutide cardiovascular benefit independent of weight loss

Dr.CardioMD Mon, Jun 8, 2026 at 6:52 AM 11 replies 302 viewsPage 3 of 3
ricardo_MIA
Member
378
1,678
Sep 2024
Miami, FL
Jun 8, 2026 at 6:11 PM#11
NurseKim_ATL said:
Albumin binding above 99% is the whole reason weekly dosing works, and it is also why the trough matters more than the peak.

This is exactly what I could not find anywhere else. I will report back once I have actually tried it.

19 19JakeSmashed95, NauseaFreeNow, SteveThurs and 16 others
Reply Quote Save Share Report
PharmD_Rodriguez
Senior Member
3,456
14,567
Jan 2024
Miami, FL
Jun 8, 2026 at 7:18 PM#12

From the other side of the consultation, briefly.

Dr.CardioMD said:
...we don't know the long-term effects of cardiovascular risk...

This is a fair point, and I think intellectual honesty requires acknowledging it. GLP-1 agonists in their current form have ~8-10 years of human exposure data. That's not nothing, but it's not 30+ years either.

However: the risk-benefit calculation should also consider the KNOWN long-term effects of untreated obesity — diabetes, cardiovascular disease, cancer, joint destruction, reduced lifespan by 5-10 years.

Uncertainty about GLP-1 long-term safety vs certainty about obesity consequences. The calculus seems clear to me, but reasonable people can disagree.

18 18TinaHashiRN, robert_kc, dan_philly and 15 others
Reply Quote Save Share Report
Dr.SleepRoch
Senior Member
1,123
5,678
Apr 2024
Rochester, MN
Jun 8, 2026 at 8:24 PM#13
NurseAsh_DET said:
Steady state is the thing most people miss.

I will push back on the "any working dose is fine" framing. The maintenance evidence sits overwhelmingly at the top studied dose, and the extension data shows regain tracking dose reduction rather than tracking stopping. Holding low is reasonable; pretending it is evidentially equivalent is not.

17 17Dr.NephBHM_UK, kim_atl_prep, sarah_TO and 14 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
dan_philly
Member
456
2,123
Jul 2024
Philadelphia, PA
Jun 8, 2026 at 9:31 PM#14
Dr.CardioMD said:
SELECT is the trial that changed the framing of this class, because it was an outcome trial rather than a weight trial: about a 20% relative reduction…
Dr.CardioMD said:
...we're creating a generation dependent on cardiovascular risk...

I understand the concern, but consider this analogy: are we "creating a generation dependent on" blood pressure medication? Cholesterol medication? Thyroid medication?

Obesity is a chronic disease with biological drivers. Treating it with medication is no different from treating any other chronic condition. The "dependency" framing implies weakness or moral failure — neither of which is accurate.

If ongoing medication is what keeps someone healthy, that's successful treatment, not dependency.

16 16Dr.CardioMD, EndoResFellow, PharmacoVig_BOS and 13 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Jun 8, 2026 at 10:38 PM#15

Moderator note: two posts asking for a source have been merged into one. Please search the thread before asking again.

15 15PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 12 others
Reply Quote Save Share Report

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
Blood pressure reduction mechanisms on GLP-1 — natriuresis18 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register